UK Approves New COVID-19 Drug Sotrovimab That May Be Effective Against Omicron
The UK has approved sotrovimab, a new COVID-19 drug that may be effective against the Omicron variant. Developed by GSK and Vir Biotechnology, the treatment reduces hospitalization and death risks by 79%.